Intriguingly, ICB-sensitive dual-loss ccRCC did not exhibit presumed indicators of immunotherapy sensitivity and instead manifested a non-infiltrated microenvironment featured by lower immune scores, suppression scores, immune-related pathways like IFN-γ and tertiary lymphoid structure (TLS) (Fig. 4A). This evidence concerns the gene IFNG and nonpapillary renal cell carcinoma.